Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kaplin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The American Journal on Addictions|June 2, 2021
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unitMike Wang, Gabriel Pinilla, Curtis Leung, et al.
Plos One|February 17, 2021
Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmissionAdam Kaplin, Caesar Junker, Anupama Kumar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2011
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenanceDaniel M Harrison, Douglas E Gladstone, Edward Hammond, et al.
Journal of Affective Disorders|February 19, 2021
Perspectives on illness-related stigma and electronically sharing psychiatric health information by people with multiple sclerosisEileen Yu, Alexis Adams-Clark, Alison Riehm, et al.
The American Journal of Medicine|January 14, 2021
The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 SurvivorsEmily Brigham, Jacqueline O'Toole, Soo Yeon Kim, et al.
Brain and Behavior|October 18, 2021
Effects of somatic treatments on suicidal ideation and completed suicidesElise M Hawkins, William Coryell, Stephen Leung, et al.
Journal of Affective Disorders|November 8, 2023
National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorderMark J Niciu, Robert C Meisner, Brent R Carr, et al.
The Lancet. Respiratory Medicine|October 22, 2021
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of careAnn M Parker, Emily Brigham, Bronwen Connolly, et al.
Psychopharmacology Bulletin|August 23, 2021
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a PrimerSagar V Parikh, Daniela Lopez, Jennifer L Vande Voort, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The American Journal on Addictions|June 2, 2021
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unitMike Wang, Gabriel Pinilla, Curtis Leung, et al.
Plos One|February 17, 2021
Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmissionAdam Kaplin, Caesar Junker, Anupama Kumar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2011
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenanceDaniel M Harrison, Douglas E Gladstone, Edward Hammond, et al.
Journal of Affective Disorders|February 19, 2021
Perspectives on illness-related stigma and electronically sharing psychiatric health information by people with multiple sclerosisEileen Yu, Alexis Adams-Clark, Alison Riehm, et al.
The American Journal of Medicine|January 14, 2021
The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 SurvivorsEmily Brigham, Jacqueline O'Toole, Soo Yeon Kim, et al.
Brain and Behavior|October 18, 2021
Effects of somatic treatments on suicidal ideation and completed suicidesElise M Hawkins, William Coryell, Stephen Leung, et al.
Journal of Affective Disorders|November 8, 2023
National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorderMark J Niciu, Robert C Meisner, Brent R Carr, et al.
The Lancet. Respiratory Medicine|October 22, 2021
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of careAnn M Parker, Emily Brigham, Bronwen Connolly, et al.
Psychopharmacology Bulletin|August 23, 2021
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a PrimerSagar V Parikh, Daniela Lopez, Jennifer L Vande Voort, et al.
Pageof 2